Increased weight gain with dolutegravir use is increasingly scrutinized in adults, but published data in paediatrics are limited and conflicting. This study aimed to provide long‐term data about changes in… Click to show full abstract
Increased weight gain with dolutegravir use is increasingly scrutinized in adults, but published data in paediatrics are limited and conflicting. This study aimed to provide long‐term data about changes in body mass index (BMI) in French children (aged 3–9 years) and adolescents (aged 10–17 years) receiving dolutegravir.
               
Click one of the above tabs to view related content.